2021
DOI: 10.1371/journal.pntd.0009089
|View full text |Cite
|
Sign up to set email alerts
|

Major risk factors and histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: A prospective case-control study on treatment outcome and their medical importance

Abstract: Over the last years, there has been a remarkable increase in the number of unresponsive patients with anthroponotic cutaneous leishmaniasis (ACL) reported worldwide. The primary objective of this study was to explore the role of demographic, clinical and environmental risk related-factors in the development of treatment failure, relapse and chronic cases compared to responsive patients with ACL. Moreover, molecular, histopathological and immunohistochemical (IHC) findings between these forms were explored. Thi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
34
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 26 publications
(36 citation statements)
references
References 45 publications
(77 reference statements)
0
34
0
2
Order By: Relevance
“…This poor adherence to treatment might play a significant role in treatment failure (Aflatoonian et al, 2019). Marital status and occupation may affect treatment outcomes (Reithinger et al, 2010;Bamorovat et al, 2018aBamorovat et al, , 2021Aflatoonian et al, 2019).…”
Section: Demographic Risk Factorsmentioning
confidence: 99%
See 2 more Smart Citations
“…This poor adherence to treatment might play a significant role in treatment failure (Aflatoonian et al, 2019). Marital status and occupation may affect treatment outcomes (Reithinger et al, 2010;Bamorovat et al, 2018aBamorovat et al, , 2021Aflatoonian et al, 2019).…”
Section: Demographic Risk Factorsmentioning
confidence: 99%
“…Clinical factors -Location of the lesion; history of chronic diseases; the number of lesions; the size of the lesion; treatment course (complete or incomplete) (Bamorovat et al, 2018a(Bamorovat et al, , 2021Aflatoonian et al, 2019) Poor treatment adherence factors Patient-related factors -Long distance from treatment setting; poor delivery of care education to family and caregivers; family support; poverty and low socioeconomic status; cultural and lay beliefs about illness and treatment; recent immigrant status; long duration of the lesion; adverse effects of treatment; absence of treatment for any reason; self-management of disease and treatment; unstable living conditions; forgetfulness; life stress; hopelessness and negative feelings; active participation in monitoring; belief of lack and poor effective drug and irregular treatment (Dunbar-Jacob and Mortimer-Stephens, 2001;WHO et al, 2003;DiMatteo, 2004) Health services-related factors -Lack of knowledge of health professionals about pain management; poor delivery of care education to the patient; the relationship between patient and health personnel; poorly developed health services; complex treatment regimens; inadequate treatment doses; a mistake in initial diagnosis; lack of clear instructions from health professionals; lack of knowledge and training for healthcare providers on managing chronic diseases (Dunbar-Jacob and Mortimer-Stephens, 2001;WHO et al, 2003;DiMatteo, 2004).…”
Section: Demographic Risk Factorsmentioning
confidence: 99%
See 1 more Smart Citation
“…After the onset of the Syrian Civil War, the number of reported cases of CL in Syria and neighboring countries has increased Du et al, 2016 ;Kanani et al, 2019 ), and because of migration, it also became more common in European countries ( United Nations High Commission for Refugees, 2017 ). L. tropica can cause chronic manifestations, lack of healing, and recurrence as late as 12 months after resolution ( Bamorovat et al, 2021 ;Khosravi et al, 2017 ).…”
Section: Introductionmentioning
confidence: 99%
“…We hypothesize that these initial PBMC-promastigote interactions contribute to define the nature and magnitude of activated or repressed host functions, ultimately determining the clinical outcome of infection. Identification of immunological signatures associated with development of more severe disease manifestations and triggered during the early phases of infection, will serve as a knowledge base for the development of prognostic tools, ultimately allowing timely intervention for these cases, known to be more refractory to first-line antileishmanial drugs (Amato et al, 2008;Maurer-Cecchini et al, 2009;Bamorovat et al, 2021).…”
Section: Introductionmentioning
confidence: 99%